NeuroSense Therapeutics Reports Year End 2025 Financial Results and Provides Business Update
March 31, 2026
Bright Minds Biosciences Announces Changes to its Executive Leadership Team, Marking the Transition to a Development Organization
June 27, 2022
Related Post
-
-
Dominari 2025 Revenue Surges 487% in 2025, Balance Sheet Strengthens Significantly
March 31, 2026
-
KALA BIO Delivers Industry-Leading AI Infrastructure: Bionic Intelligence Research Agent Now Live
March 30, 2026
-
Tempest Reports Year End 2025 Financial Results and Provides Business Update
March 30, 2026